Philippe Lienard, Independent CMC and technology consultant

Langues

Anglais
Bilingue ou natif
Espagnol
Notions

Préférences en matière de lieu de travail

Accepte de travailler sur site

Paris (jusqu’à 50 km)

AB Consulting
Independent CMC and technology consultant
INDUSTRIE PHARMACEUTIQUE
avril 2022 - Aujourd'hui (4 ans et 2 mois)
Paris, France
- Consultancy for small biopharma compagnies e.g., Epimonipharm (USA based startup in health life), ICM (small molecules targeting brain cancer), Corteria (peptides development), and Aisa therapeutics (terpenes against inflammation).
Sanofi Research - Vitry
CMC project leader
INDUSTRIE PHARMACEUTIQUE
septembre 2017 - mars 2024 (6 ans et 6 mois)
Vitry-sur-Seine, France
- Assumed a lead role in research and development teams as CMC expert.
- Successful elaboration of strategic plans to support project transitions from research to pre-clinical development phase.
- Applied several innovations and up-to-date technologies for the new chemical entities, e.g. small molecules and peptides.
- Business plan for a European unique nanoparticle manufacturing platform for clinical use.
o Key accomplishment: elaboration of integrated CMC strategies drug substance/drug product up to FIM and PoC.
Sanofi Research
Business development
INDUSTRIE PHARMACEUTIQUE
mars 2014 - juillet 2018 (4 ans et 4 mois)
Vitry-sur-Seine, France
- Business plan for a European unique nanoparticle manufacturing platform for clinical use.
o Key achievement in this role: asset sale contract with an external partner V Nano company (320 k€).

Consulter toutes les expériences de Philippe

Soyez le premier à recommander Philippe

Contribuez à la réussite de ce freelance en partageant votre expérience de collaboration avec lui.

A

Agatha Frydrych

Backend Java Software Engineer

4.7

(3)

2

B

Baptiste Duhen

Fullstack developer

4.6

(4)

5

A

Amed Hamou

Senior Lead Developer

4

(2)

7

A

Audrey Champion

Web developer

4.3

(3)

4

S’inscrire pour les voir

Ph D in Organic Chemistry University Paris XI - Orsay - France
University Paris XI
1991
- Asymmetric synthesis of biologically active compounds related to podophyllotoxin and steganon to discover new potential anticancer. ICSN/ CNRS - Gif-sur-Yvette (Professor H.-P. Husson)